521 U.S. 642 (1997)
In July 1988 Grand Metropolitan PLC retained the Minneapolis law firm Dorsey & Whitney as local counsel in connection with a potential tender offer for the common stock of the Pillsbury Company.1 James Herman O'Hagan was a partner at Dorsey & Whitney but performed no work on the Grand Met matter.2 Both Grand Met and the firm took steps to keep the tender offer plans confidential.3 Dorsey & Whitney withdrew from the representation on September 9, 1988.4
On August 18, 1988, while the firm still represented Grand Met, O'Hagan began purchasing call options on Pillsbury stock.5 He continued buying options through September and ultimately held 2,500 unexpired Pillsbury call options.6 In September he also purchased approximately 5,000 shares of Pillsbury common stock at a price just under $39 per share.7
On October 4, 1988, Grand Met publicly announced its tender offer.8 The price of Pillsbury stock rose to nearly $60 per share.9 O'Hagan sold his options and shares, realizing a profit of more than $4.3 million.10
The Securities and Exchange Commission investigated the trading and obtained a 57-count indictment charging O'Hagan with mail fraud, securities fraud under § 10(b) and Rule 10b-5 on a misappropriation theory, fraudulent trading in connection with a tender offer under § 14(e) and Rule 14e-3(a), and money laundering.11 A jury convicted him on all counts and the district court imposed a 41-month prison sentence.12
A divided panel of the Eighth Circuit reversed all convictions, holding that the misappropriation theory does not support liability under § 10(b) and that Rule 14e-3(a) exceeds the Commission's authority under § 14(e).13 The Supreme Court granted certiorari.14
Whether a person who trades in securities for personal profit, using confidential information misappropriated in breach of a fiduciary duty to the source of the information, is guilty of violating § 10(b) and Rule 10b-5?15
The misappropriation theory holds that a person commits fraud "in connection with" a securities transaction, and thereby violates § 10(b) and Rule 10b-5, when he misappropriates confidential information for securities trading purposes, in breach of a duty owed to the source of the information.16 Under this theory, a fiduciary's undisclosed, self-serving use of a principal's information to purchase or sell securities, in breach of a duty of loyalty and confidentiality, defrauds the principal of the exclusive use of that information.17
Yes. O'Hagan, as a partner at Dorsey & Whitney, owed a fiduciary duty to the firm and its client Grand Met regarding the confidential tender offer plans.18 He misappropriated that information by purchasing Pillsbury call options and common stock for personal profit without disclosing his trading plans to the source.19 The deception through nondisclosure was consummated precisely when O'Hagan executed the securities transactions, satisfying the statutory requirement that the deceptive device be used "in connection with" the purchase or sale of securities.20
Yes, such a person is guilty of violating § 10(b) and Rule 10b-5 under the misappropriation theory.21
Related opinions on this issue
Scalia joined Parts I, III, and IV of the majority opinion but dissented from Part II addressing the misappropriation theory under § 10(b) and Rule 10b-5.22 He maintained that the principle of lenity applicable to criminal statutes requires construing the unelaborated statutory language to demand manipulation or deception of a party to the securities transaction itself.23 Scalia observed that the majority's explanation might be reasonable in other contexts but does not accord with lenity when applied to this criminal provision.24
He concluded that respondent's actions either violated the statute or did not, independent of the government's particular theory.25
Joined by The Chief Justice
Thomas dissented from the misappropriation theory, contending that it fails to provide a coherent and consistent interpretation of § 10(b)'s "in connection with" requirement.26 He argued that the fraud is not necessarily consummated only by a securities transaction because the misappropriated information could be put to other uses, such as sale to a newspaper or delivery to Pillsbury itself.27 Thomas noted that the majority implicitly conceded the indefensibility of the Commission's theory by substituting an "ordinarily" standard never adopted by the agency.28
He concluded that the majority's new theory is a post hoc rationalization that cannot support the convictions.29
Whether the Commission exceeded its rulemaking authority by adopting Rule 14e-3(a), which proscribes trading on undisclosed information in the tender offer setting, even in the absence of a duty to disclose?30
Under § 14(e), the Commission may prescribe means reasonably designed to prevent fraudulent acts in connection with tender offers, and Rule 14e-3(a) qualifies as such a prophylactic measure even without requiring a breach of fiduciary duty because it addresses situations where breach of duty is likely but difficult to prove.31
No. Rule 14e-3(a) is a means reasonably designed to prevent fraudulent trading on material nonpublic information in the tender offer context.32 It reaches trading where a breach of duty is likely but difficult to prove, such as when a tippee trades on information received from an insider, thereby assuring the efficacy of Williams Act protections without demanding specific proof of fiduciary breach in every case.33
No, the Commission did not exceed its rulemaking authority by adopting Rule 14e-3(a).34
Related opinions on this issue
Joined by The Chief Justice
Thomas dissented from upholding Rule 14e-3(a) as applied to misappropriation cases.35 He argued that the rule exceeds the Commission's authority because it prohibits nonfraudulent acts without being reasonably designed to prevent underlying fraud.36 Thomas maintained that there is no particular difficulty in proving breach of duty when the source of the information is the bidder itself, as the victim of the fraud would readily provide evidence.37
He concluded that the rule's elimination of the fiduciary duty requirement cannot be justified as a prophylactic measure under § 14(e).38